| Identification | Back Directory | [Name]
3-butyryl-4-(2-methylphenylamino)-8-methoxyquinoline | [CAS]
115607-61-9 | [Synonyms]
3-butyryl-4-(2-methylphenylamino)-8-methoxyquinoline
1-Butanone, 1-[8-methoxy-4-[(2-methylphenyl)amino]-3-quinolinyl]-
1-[8-METHOXY-4-[(2-METHYLPHENYL)AMINO]-3-QUINOLINYL]-1-BUTANONE(WXG00349) | [Molecular Formula]
C21H22N2O2 | [MDL Number]
MFCD00865646 | [MOL File]
115607-61-9.mol | [Molecular Weight]
334.41 |
| Chemical Properties | Back Directory | [Boiling point ]
473.2±45.0 °C(Predicted) | [density ]
1.162±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
3.95±0.50(Predicted) |
| Hazard Information | Back Directory | [Uses]
SKF96067 is a reversible inhibitor of the gastric H+/K+-ATPase. | [References]
[1] Keeling DJ, et al. SK&F 96067 is a reversible, lumenally acting inhibitor of the gastric (H+ + K+)-ATPase. Biochem Pharmacol. 1991 Jun 21;42(1):123-30. DOI:10.1016/0006-2952(91)90690-7 |
|
| Company Name: |
Nextpeptide Inc
|
| Telephone: |
+86-0571-81612335 +8613336028439 |
| Website: |
http://www.nextpeptide.com/ |
|